Add like
Add dislike
Add to saved papers

Antimicrobial resistance of bovine Salmonella enterica ssp. enterica isolates from the Alberta Agriculture and Forestry Disease Investigation Program (2006-2014).

The objectives of this study were to describe the antimicrobial susceptibility and serotypes of clinical Salmonella spp. isolates from Alberta cattle, to inform antimicrobial stewardship decisions for Alberta bovine veterinarians and to provide data for national surveillance. Isolates were collected from cattle and serotyped by Alberta Agriculture and Forestry from 2006 to 2014. Susceptibility testing was completed using Canadian surveillance breakpoints. There were 81 unique Salmonella isolates from 72 visits to 27 farms. The majority of isolates were S. Typhimurium (66.7%) and S. Dublin (19.8%). The prevalence of multidrug resistance was high in S. Typhimurium (89.1%) and S. Dublin (93.8%), including ceftiofur resistance (43.6% and 68.8%, respectively), while there was no resistance in other serotypes. As ceftiofur is a recommended treatment option for enteritis and septicemia caused by Salmonella in cattle, these results reinforce that obtaining bacterial culture and susceptibility results is critical for suspected cases of bovine salmonellosis in Alberta.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app